Insights

3D Systems Secures FDA Clearance to Broaden Adolescent Use of VSP Orthopedics Platform

3D Systems Secures FDA Clearance to Broaden Adolescent Use of VSP Orthopedics Platform

December 18, 2025 Medical

US-based 3D printer manufacturer 3D Systems has received U.S. Food and Drug Administration 510(k) clearance broadening the approved use of its VSP Orthopedics virtual surgical planning and patient-specific instrumentation platform. The clearance now covers skeletally mature adolescents with normal bone structure, in addition to adult patients. This change removes previous regulatory constraints that limited use in adolescent cases and formally brings these procedures within the platform’s labeled indications.

Read More

News

We realize your creation

FacFox provides one-stop solution with comprehensive on-demand manufacturing capabilities and data-driven analysing technologies, see our available service, feel free to reach us to realize your creation!

Most Viewed

138241adae16d0825542707430777355.jpg

INTAMSYS installed over 1,500 high temperature 3D printers to date Money & Funding

INTAMSYS reported that it has sold over 1,500 AM systems for high-performance materials such as PEEK, PEKK, PAEK and PEI to date. The Chinese manufacturer, whose name stands for INtelligent AM SYStems, has strived to make this technology industrially mature since its start in 2013. Last year only, almost 500 FUNMAT HT, the industrial entry-level system, were sold worldwide.

0ea4798653e8ae192e4afa5b75a866a0.jpg

SLA provider Nexa3D acquires laser sintering company NXT Factory AM Industry

Nexa3D, a manufacturer of ultra-fast SLA 3D printers, has just announced the acquisition of NXT Factory, a developer of Quantum Laser Sintering (QLS) 3D printing technology. Through the deal, Nexa3D is acquiring all outstanding shares of NXT Factory, and will begin to offer both high-speed 3D printing processes through its AM portfolio. The acquisition will also see Nexa3D add a range of powder fusion plastic materials to its product line.